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Abstract 
Transgenic fish species can be routinely produced by transferring foreign 
DNA into developing embryos via microinjection or electroporation. This 
technology offers an excellent opportunity for modifying or improving the 
genetic traits of commercially important Fishes, mollusks, and crustaceans for 
aquaculture. Studies have shown that administration of recombinant fish or 
mammalian growth hormone (GH) to juvenile fish or oysters resulted in 
significant growth enhancement. Thus, it is possible to improve the growth 
rates of marine animals by manipulating GH or its gene. This paper reviews the 
results of studies to determine the efficacy of recombinant fish GH in improving 
the growth rates of fishes, mollusks, and crustaceans, and of gene transfer 
technology in producing fast-growing transgenic animals. 
Introduction 
The worldwide harvest of fishery products traditionally depends upon the natural 
populations of fishes, mollusks, and crustaceans from fresh and marine waters. Due to the rapid 
increase in consumption of fishery products by the general public, as well as uncontrolled fishing 
and poor management, the total annual harvest has already approached the maximum potential of 
about 150 million tons as forecast by the US Department of Commerce. Accumulation of 
chemical pollutants in aquatic environments has further affected the fisheries production. A 
number of regions have experienced significant declines in the catches of important species such as 
salmon, striped bass, sturgeons, eels, jacks, mullets, mackerel, abalones, oysters and crabs (FAO 
1986). Fishing fleets now travel great distances to exploit more productive areas. They have 
switched to alternative species and begun to employ a variety of sophisticated technologies. These 
developments have caused significant increases in fish prices. 
In the past decades, many countries have turned to aquaculture to increase fish production. 
In 1992, the world production from aquaculture exceeded 17 million tons, about 32.2% of the total 
fisheries production (Csavas 1995). Thus, aquaculture has the potential to substantially meet the 
world demand for fishery products. 
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The success of aquaculture depends on: (1) complete control of reproduction and the life 
cycle, (2) excellent genetic background of the broodstock, (3) efficient detection and effective 
prevention of diseases, (4) thorough understanding of the optimal physiological, environmental, 
and nutritional conditions for growth and development, (5) sufficient supply of good quality water; 
and (6) innovative management techniques. By improving some of these factors, the aquaculture 
industry has already made impressive progress over the last several years. The application of 
molecular biology and biotechnology will further speed up the expansion of the industry. These 
applications include enhancing growth rates, controlling reproductive cycles, improving feed 
composition, producing new vaccines, and developing disease-resistant and hardier genetic stocks. 
Over the last several years, our laboratory and others have been searching for innovative strategies 
to increase fish production by applying the methods of contemporary molecular biology and 
biotechnology. In this paper, I will summarize results of our studies and those of many others to 
demonstrate the efficacy of modern biological techniques, including transgenic fish technology, in 
increasing the production from aquaculture. 
Effect of Recombinant Fish Growth Hormone on Somatic Growth 
Thanks to the rapid advances in recombinant DNA technology, complementary DNA 
(cDNA) and the genomic sequence of growth hormone (GH) have been isolated and characterized for 
several fish species in recent years (Gill et al. 1985, Agellon and Chen 1986, Gonzales-Villaseñor 
et al. 1986, Momota et al. 1988, Watahiki et al. 1989). Our laboratory has prepared biologically 
active recombinant GH by expressing rainbow trout (rt) GH1 cDNA in E. coli cells (Agellon et al. 
1988). Since rainbow trout GH molecule is highly hydrophobic, the resulting polypeptide 
synthesized in E. coli cells forms insoluble inclusion bodies, which are inactive but can be easily 
recovered by differential centrifugation. The protein is dissolved in a 100 mM Tris buffer pH 9.0 
with 8 M urea. Renaturation of the recombinant hormone is carried out by slowly diluting the 
solution to 4.5 M urea and the protein concentration below 0.5 mg/ml while stirring gently at 
40°C for 24 hours. The biological activity of the resulting hormone preparation is assessed by its 
ability to stimulate the uptake of radioactive sulfate into gill cartilage in vitro and the 
accumulation of insulin-like growth factor (IGF)-I in the liver in vivo. 
Agellon et al. (1988) showed in a series of studies that application of this recombinant 
hormone to yearling rainbow trout resulted in a significant growth enhancement. After treatment 
with the recombinant rtGH for four weeks at a dose of 1 mg/g body weight each week, the weight 
gain among the hormone-treated rainbow trout was two times greater than among the controls. 
Significant length gain was also evident in hormone-treated animals. When the same recombinant 
hormone was administered to small juvenile rainbow trout by immersing them in GH-containing 
solutions, the same growth-promoting effect was also observed (Table 1; also Leong and Chen, 
unpublished results). These results are in agreement with those reported by Sekine et al. (1985), 
Gill et al. (1985), and others (Schulte et al. 1986, Sato et al. 1988a, 1988b, Moriyama et al. 
1990). However, it is important to mention that the growth enhancement effect of the 
biosynthetic hormone was markedly reduced when more than 2 mg/g was applied to the test 
animals (Agellon et al. 1988). These results suggest that when the total amount of GH exceeds 
the maximal threshold level, homeostasis is disturbed and growth is affected. 
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Table 1. Effect of recombinant growth hormone (GH) treatment on the growth of 
young juvenile rainbow trout. Values are mean±SE (n=15). Data from 
Agellon et al. (1988) with permission. 
Groups of rainbow trout were subjected to osmotic shock in the presence or absence of 
recombinant GH. Weight was measured before and after 5 weeks of treatment. Final weights 
were not significantly different between the two GH treatments but both differed from the 
control. 
Several years ago, Morse (1984) reported that bovine insulin and bovine GH enhanced the 
growth rate of California red abalone. Recently, Paynter and Chen (1991) found that dipping the 
spats or juveniles of the oyster Crassostrea virginica in solutions of recombinant rtGH 
polypeptide (10-100 nM) also resulted in significant increases in shell size, wet weight, and dry 
weight (Table 2). Oysters treated with recombinant rtGH, native bovine GH, or bovine insulin 
consumed more oxygen per unit time than controls. These findings suggest that recombinant fish 
GH can be used to enhance the growth rate of mollusks under intensive culture conditions. They 
further suggest that growth in mollusks may also be regulated by hormonal factors similar to 
mammalian GH and insulin-like growth factors (IGFs). 
Table 2. Effect of recombinant rainbow trout growth hormone exogenously applied to oysters 












































In order to realize the potential of recombinant GH to enhance the somatic growth rate of 
cultured fish, a series of studies has to be conducted. These studies include: (1) route of hormone 
delivery, (2) effective dose of hormone, (3) regimen of hormone administration, (4) nutritional 
requirement, (5) effect of environmental factors, (6) effect of chronic and acute GH treatment, and 
(7) effect of fish GH on human consumers. 
Treatment 
Saline control 
GH 50 mg/l 

















Transgenic Fish Harboring Growth Hormone Gene 
Although exogenous application of recombinant GH results in significant growth 
enhancement in fish, it may not be cost-effective. If new strains of fish producing elevated but 
optimal levels of GH can be produced, it would bypass many of the problems with exogenous GH 
treatment. Moreover, once these fish strains have been generated, they would be far more cost-
effective than their ordinary counterparts because the fish would produce and deliver the hormone 
and transmit the enhanced growth characteristics to their offspring. 
Gene transfer methodology 
Animals into which a segment of foreign DNA has been introduced and stably integrated 
into the host genome are called 'transgenic' Since Constantini and Lacy's (1981) transgenic mice, 
many other transgenic animals including livestock and fishes have been constructed successfully 
(Palmiter et al. 1982, Gordon and Ruddle 1985, Hammer et al. 1985, Ozato et al. 1986, Dunham 
et al. 1987, Pursel et al. 1989, Chen and Powers 1990, Chen et al. 1993). These animals play 
important roles both in basic research as well as in biotechnology application. Various methods 
have been used to deliver foreign DNA into somatic cells and germlines of mammals and other 
higher vertebrates. The methods include direct microinjection, retrovirus infection, electroporation, 
calcium phosphate precipitation, and particle-gun bombardment. Direct microinjection of DNA 
into the male pronuclei of the fertilized eggs has been the prevalent method. 
The microinjection method has been used to deliver foreign genes into several fish species 
in recent years. These include goldfish (Zhu et al. 1985), medaka (Ozato et al. 1986, Lu et al. 
1992), rainbow trout (Chourrout et al. 1986), salmon (Fletcher et al. 1988), tilapia (Brem et al. 
1988), zebrafish (Stuart et al. 1988), common carp (Zhang et al. 1990, Chen et al. 1993), and 
catfish (Dunham et al. 1992, Powers et al. 1991). In general, gene transfer in fish by 
microinjection is carried out as follows. Eggs and sperm are collected into separate dry containers. 
Fertilization is initiated by adding water and sperm to eggs and stirring gently. Eggs are water-
hardened for various periods of time and then rinsed. Microinjection is done within the first two 
hours after fertilization. The equipment consists of a dissecting stereomicroscope and two 
micromanipulators, one with a microneedle for injecting DNA into the embryos and the other with 
a micropipette for holding the embryos in position during the injection. Since the male pronuclei 
of the fish embryos studied to date are not visible, the foreign genes are usually injected into the 
egg cytoplasm and the amount of the DNA injected into each embryo is in the range of one 
million copies or higher. In zebrafish and medaka, natural spawning can be induced by adjusting 
photoperiod and water temperature and newly fertilized embryos can be readily collected for 
microinjection. Within the first two hours after fertilization, the micropyle of the embryo is still 
visible under the microscope. The DNA solution can be easily delivered into the embryos with a 
microneedle through the micropyle (Stuart et al. 1988, Lu et al. 1992). 
Although the microinjection method is successful in transferring foreign DNA into fish 
embryos, it is very laborious and time-consuming. There is interest in developing convenient 
mass gene transfer technologies for use in fish transgenesis. Among the mass gene transfer 
methods are particle-gun bombardment, electroporation, and those mediated by retroviruses, 
liposomes, or sperm. Electroporation is the most effective means of transferring foreign genes 
into fish embryos. This method uses a series of short electrical pulses that change the membrane 
permeability and thereby permit the entry of DNA molecules into embryos. Lu et al. (1992) 
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showed that the rate of foreign gene integration in transgenic medaka produced by electroporation 
was 20% or higher. Powers et al. (1992) recently reported a much higher rate of gene transfer in 
common carp and channel catfish with the same electroporator. The rate of transgene integration 
in transgenic medaka produced by electroporation was only slightly higher than that of 
microinjection, but it takes much less time to produce large numbers of transgenic fish by 
electroporation. 
Transgenic fish harboring growth hormone gene 
Zhu et al. (1985) reported the first successful transfer into goldfish and loach of human 
GH gene fused to a mouse metallothionein gene promoter. According to Zhu (personal 
communication), the F1 offspring of these transgenic fish grew twice as large as their non-
transgenic siblings. Unfortunately, Zhu and his colleagues failed to present compelling evidence 
for integration and expression of the foreign genes in their transgenic fish. Recently, our 
laboratory as well as many other laboratories throughout the world have successfully confirmed 
Zhu's work by demonstrating that human or fish GH and many other genes can be readily 
transferred into embryos of a number of fish species and integrated into the genome of the host fish 
(for review, see Chen and Powers 1990). While several groups have demonstrated expression of 
foreign genes in transgenic fish, only Zhang et al. (1990), Du et al. (1992) and Lu et al. (1992) 
have documented that a foreign GH gene could be: (a) transferred to the target fish species, 
(b) integrated into the fish genome, and (c) genetically transmitted to subsequent generations. 
Furthermore, the expression of the foreign GH gene may result in enhancement of growth rates of 
both P1 and F1 generations of transgenic fish (Zhang et al. 1990, Lu et al. 1992). 
In gene transfer studies on common carp and channel catfish, about 106 molecules of a 
linearized recombinant plasmid containing the long terminal repeat (LTR) sequence of avian Rous 
sarcoma virus (RSV) and the rainbow trout GH1 or GH2 cDNA were injected into the cytoplasm 
of one-, two- and four-cell embryos (Zhang et al. 1990, Chen et al. 1990, 1993, Powers et al. 
1991, Dunham et al. 1992). Genomic DNA samples extracted from the pectoral fins of 
presumptive transgenic fish were then analyzed for the presence of RSVLTR-rtGHl-cDNA by 
PCR amplification, followed by Southern blot hybridization of the amplified DNA samples. 
About 35% of the injected carp embryos survived at hatching and about 10% of the survivors had 
integrated the RSVLTR-rtGH1-cDNA sequence (Zhu et al. 1985, Chen and Powers 1990, Chen et 
al. 1990, Zhang et al. 1990, Du et al. 1992, Lu et al. 1992). Southern-blot analysis of genomic 
DNA from several transgenic carps revealed that a single copy of the RSVLTR-rtGH1-cDNA 
sequence was integrated at multiple chromosomal sites (Zhang et al. 1990). 
When an RSVLTR-csGH-cDNA construct was injected into catfish embryos, about 10% 
of the fish also turned out transgenic (Powers et al. 1991, Dunham et al. 1992). In microinjected 
medaka, 20-30% of the hatched individuals integrated the foreign gene, suggesting that DNA 
microinjected via the micropyle may have better access to the nucleus situated right beneath it 
(Lu et al. 1992). 
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Inheritance and Expression of Foreign Growth Hormone Gene 
in Transgenic Fish 
The patterns of inheritance of RSVLTR-rtGH1 cDNA in transgenic common carp were 
studied by fertilizing eggs collected from non-transgenic females or P1 transgenic females with 
sperm samples of several sexually mature P1 male transgenic fish (Chen et al. 1993). The DNA 
samples extracted from the resulting F1 progeny were assayed for the presence of RSVLTR-rtGH1 -
cDNA sequence by PCR amplification and dot-blot hybridization. The percentage of transgenic 
progeny resulting from nine matings were 0, 32, 26, 100 (4 progeny only), 25, 17, 31, 30, and 
23. If each of the transgenic parents in these nine matings carried at least one copy of the 
transgene in the gamete cell, about 50-75% transgenic progeny would have been expected in each 
pairing. Of these nine matings, two sib lots, both control x P1, gave transgenic progeny as many 
as or more than expected. The other matings gave less than expected numbers of transgenic 
progeny. These results indicate that although most of these P1 transgenic fish had RSVLTR-
rtGH1 cDNA in their germline, they might be mosaics. Similar patterns of mosaicism in the 
germline of P1 transgenic fish have been observed in many fish species studied to date (Ozato et al. 
1986, Dunham et al. 1987, 1992, Stuart et al. 1988, Zhang et al. 1990, Lu et al. 1992). 
If the transgene carries a functional promoter, some of the transgenic individuals are 
expected to express the transgene activity. Many of the P1 and F1 transgenic common carp 
produced rtGH at levels that varied about 10-fold (Zhang et al. 1990, Chen et al. 1993). Chen et 
al. (1993) recently detected rtGH mRNA in the F1 transgenic carp with an assay involving reverse 
transcription, PCR amplification, and RNA dot-blot hybridization. Different levels of rtGH 
mRNA were detected in liver, eyes, gonads, intestine and muscle of the F1 transgenic individuals. 
Growth Performance of Fish Transgenic for Growth Hormone 
Since the site of transgene integration differs among the individuals in any population of 
P1 transgenic fish, they should be considered as totally different transgenic individuals and cannot 
be directly compared for growth performance among themselves. Instead, the growth studies 
should be conducted in F1 transgenic and non-transgenic siblings derived from the same family. 
Chen et al. (1993) evaluated the growth of F1 transgenic carp in seven families. In these 
experiments, transgenic and non-transgenic full siblings were spawned, hatched, and reared 
communally under the same environment. Results showed that growth of F1 transgenic 
individuals in response to rtGH1 cDNA varied widely. The seven trials showed that transgenics 
grew 20, 40, 59, and 22% faster, or 27, 15 and 2% slower than non-transgenic full siblings. 
In three of the four families where F1 transgenics grew faster than their non-transgenic 
full siblings, the highest and lowest body weights of the transgenics were larger than those of the 
non-transgenics. In the fourth family, the minimum but not the maximum body weight of the 
transgenics was larger than that of the non-transgenics. In two of the three transgenic families in 
which the transgenic siblings grew slower than the non-transgenics, the lowest and highest body 
weights of the transgenics were less than those of the non-transgenics. In the third family, 
however, one of the F1 transgenics was the largest fish in the family. Since the response of the 
transgenic fish to the insertion of the RSVLTR-rtGH1 cDNA appears to variable, as a result of 
random integration of the transgene, the fastest growing genotype will likely be developed by 
utilizing a combination of family selection and mass selection of transgenic individuals after the 
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insertion of the foreign gene. Among transgenic medaka carrying chicken b-actin gene promoter 
human GH gene construct, the F1 transgenics grew significantly faster than the non-transgenic 
siblings (Lu et al. 1992). 
In an effort to study the biological effect of elevated levels of IGF-I on somatic growth, 
transgenic medaka harboring trout IGF cDNA driven by carp b-actin gene promoter have been 
produced in our laboratory. Both P1 and F1 IGF-I transgenic medaka hatched two days earlier than 
their non-transgenic siblings. The P1 transgenics also grew faster than the non-transgenics. 
General Conclusion and Prospective 
Transgenic fish technology has great potential in the aquaculture industry. By introducing 
desirable genetic traits into fishes, mollusks, and crustaceans, superior transgenic strains can be 
produced for aquaculture. These traits include faster growth rates, improved food conversion 
efficiency, resistance to some known diseases, tolerance to low oxygen concentrations, and 
tolerance to extreme temperatures. Our laboratory and those of others have shown that transfer, 
expression and inheritance of fish growth hormone transgenes can be achieved in several fish 
species and that the resulting transgenics grow substantially faster than their non-transgenic 
siblings. This is a vivid example of the potential application of the gene transfer technology to 
aquaculture. 
However, to realize the full potential of the transgenic fish technology in aquaculture or 
other biotechnological applications, several important scientific breakthroughs are required. These 
include: (1) more efficient technologies for mass gene transfer, (2) targeted gene transfer 
technologies such as embryonic stem cell gene transfer or ribozyme gene inactivation, (3) suitable 
promoters to direct the expression of transgenes at optimal levels during the desired developmental 
stages, (4) identified genes of desirable traits for aquaculture and other applications, (5) information 
on the physiological, nutritional, immunological and environmental factors that maximize the 
performance of the transgenics, and (6) safety and environmental impacts of transgenic fish. Once 
these problems are resolved, the commercial application of the transgenic fish technology will be 
readily attained. 
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